Anders Johansson

1.5k total citations
43 papers, 1.2k citations indexed

About

Anders Johansson is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Anders Johansson has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Epidemiology. Recurrent topics in Anders Johansson's work include Parkinson's Disease Mechanisms and Treatments (28 papers), Neurological disorders and treatments (23 papers) and Restless Legs Syndrome Research (6 papers). Anders Johansson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (28 papers), Neurological disorders and treatments (23 papers) and Restless Legs Syndrome Research (6 papers). Anders Johansson collaborates with scholars based in Sweden, United States and Denmark. Anders Johansson's co-authors include Dag Nyholm, Håkan Askmark, Sten‐Magnus Aquilonius, Per Odin, Kaj Blennow, Mevludin Memedi, Tommy Lewander, Peter A. LeWitt, Christofer Lundqvist and Ingela Nygren and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Medicine & Science in Sports & Exercise.

In The Last Decade

Anders Johansson

42 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anders Johansson 721 214 186 160 153 43 1.2k
Ying Wu 789 1.1× 168 0.8× 222 1.2× 123 0.8× 216 1.4× 80 1.1k
Anna Zecchinelli 1.1k 1.5× 209 1.0× 326 1.8× 126 0.8× 142 0.9× 46 1.5k
Livia Pasquali 428 0.6× 259 1.2× 289 1.6× 177 1.1× 393 2.6× 60 1.4k
Eduardo De Pablo‐Fernández 1.1k 1.5× 222 1.0× 307 1.7× 154 1.0× 247 1.6× 45 1.5k
Stefanie Lerche 634 0.9× 279 1.3× 170 0.9× 105 0.7× 323 2.1× 37 1.1k
Naveed Malek 975 1.4× 270 1.3× 265 1.4× 96 0.6× 146 1.0× 48 1.4k
Yusaku Nakamura 445 0.6× 231 1.1× 191 1.0× 67 0.4× 389 2.5× 50 1.1k
Kenichi Yasui 459 0.6× 108 0.5× 140 0.8× 268 1.7× 233 1.5× 32 1.1k
Tae‐Beom Ahn 731 1.0× 202 0.9× 308 1.7× 129 0.8× 224 1.5× 73 1.2k
Gholam Ali Shahidi 947 1.3× 282 1.3× 315 1.7× 216 1.4× 414 2.7× 92 1.6k

Countries citing papers authored by Anders Johansson

Since Specialization
Citations

This map shows the geographic impact of Anders Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Johansson more than expected).

Fields of papers citing papers by Anders Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Johansson. The network helps show where Anders Johansson may publish in the future.

Co-authorship network of co-authors of Anders Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Johansson. A scholar is included among the top collaborators of Anders Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Johansson. Anders Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergquist, Filip, Per Odin, Anders Johansson, et al.. (2024). Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. European Journal of Neurology. 32(1). e16582–e16582. 3 indexed citations
2.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2024). Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion. Movement Disorders Clinical Practice. 11(9). 1095–1102. 3 indexed citations
3.
Bergquist, Filip, M. Ehrnebo, Dag Nyholm, et al.. (2022). Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease. Neurology. 99(10). e965–e976. 15 indexed citations
4.
Johansson, Anders, et al.. (2021). Personalized Medicine Approach in Treating Parkinson’s Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice. Journal of Personalized Medicine. 11(8). 720–720. 13 indexed citations
5.
Hagell, Peter, et al.. (2020). Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease. Journal of Neurology. 267(11). 3411–3417. 4 indexed citations
6.
Bártek, Jiří, et al.. (2020). Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness Study. Stereotactic and Functional Neurosurgery. 98(5). 331–336. 4 indexed citations
7.
Franzén, Erika, et al.. (2020). A Pilot Study of the Feasibility and Effects of Table Tennis Training in Parkinson Disease. SHILAP Revista de lepidopterología. 2(3). 100064–100064. 6 indexed citations
8.
Buvarp, Dongni, Ilias Thomas, Anders Ericsson, et al.. (2019). Evaluation of a sensor algorithm for motor state rating in Parkinson's disease. Parkinsonism & Related Disorders. 64. 112–117. 5 indexed citations
9.
Buvarp, Dongni, Anders Ericsson, Anders Johansson, et al.. (2018). Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry. CNS Neuroscience & Therapeutics. 24(5). 439–447. 23 indexed citations
10.
Svenningsson, Per, Anders Johansson, Dag Nyholm, et al.. (2018). Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial. npj Parkinson s Disease. 4(1). 35–35. 19 indexed citations
11.
Memedi, Mevludin, Dag Nyholm, Anders Johansson, et al.. (2015). Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease. IEEE Journal of Biomedical and Health Informatics. 19(6). 1829–1834. 13 indexed citations
12.
Memedi, Mevludin, Dag Nyholm, Anders Johansson, et al.. (2013). Self-reported symptoms and motor tests via telemetry in a 36-month levodopa-carbidopa intestinal gel infusion trial. Dalarna University College Electronic Archive. 2 indexed citations
13.
Nyholm, Dag, Per Odin, Anders Johansson, et al.. (2012). Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients. The AAPS Journal. 15(2). 316–323. 94 indexed citations
14.
Westin, Jerker, Dag Nyholm, Anders Johansson, et al.. (2010). 12-month results from a novel test battery used in a duodenal levodopa infusion trial. European Journal of Neurology. 17. 21–21. 2 indexed citations
15.
Nyholm, Dag, et al.. (2010). Circadian Rhythmicity in Levodopa Pharmacokinetics in Patients With Parkinson Disease. Clinical Neuropharmacology. 33(4). 181–185. 22 indexed citations
16.
Westin, Jerker, Mevludin Memedi, Dag Nyholm, et al.. (2009). A successful computer method for assessing drawing impairment in Parkinson's disease. European Journal of Neurology. 16. 559–559. 1 indexed citations
17.
Johansson, Anders, Henry Engler, Gunnar Blomquist, et al.. (2007). Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET. Journal of the Neurological Sciences. 255(1-2). 17–22. 108 indexed citations
18.
Ramström, Margareta, Anders Johansson, Håkan Askmark, et al.. (2004). Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry. PROTEOMICS. 4(12). 4010–4018. 57 indexed citations
19.
Johansson, Anders, Anders Larsson, Ingela Nygren, Kaj Blennow, & Håkan Askmark. (2003). Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis. Neuroreport. 14(14). 1867–1869. 21 indexed citations
20.
Nygren, Ingela, Anders Larsson, Anders Johansson, & Håkan Askmark. (2002). VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Neuroreport. 13(17). 2199–2201. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Wu Breakdown of academic impact, for papers by Anna Zecchinelli Breakdown of academic impact, for papers by Livia Pasquali Breakdown of academic impact, for papers by Eduardo De Pablo‐Fernández Breakdown of academic impact, for papers by Stefanie Lerche Breakdown of academic impact, for papers by Naveed Malek Breakdown of academic impact, for papers by Yusaku Nakamura Breakdown of academic impact, for papers by Kenichi Yasui Breakdown of academic impact, for papers by Tae‐Beom Ahn Breakdown of academic impact, for papers by Gholam Ali Shahidi
Rankless by CCL
2026